Changes in the Small Noncoding RNAome During M1 and M2 Macrophage Polarization

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Macrophages are key immune cells involved in phagocytosis and immune regulation.
• Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs, snoRNAs, and snRNAs, play crucial roles in cellular functions.
• Macrophage polarization into distinct functional states (M1 and M2) is critical for immune responses.

Purpose of the Study:

• To investigate the expression profiles of the small noncoding RNAome during macrophage polarization.
• To identify specific sncRNAs that are differentially expressed during M1 and M2 macrophage polarization.
• To explore the functional roles of identified sncRNAs in regulating macrophage activity and immune responses.

Main Methods:

• High-throughput sequencing was employed to analyze the expression of various sncRNAs.
• Quantitative PCR (qPCR) was used to validate expression changes.
• Functional assays were conducted to assess the impact of specific sncRNAs on macrophage functions, such as cytokine production and antitumor activity.

Main Results:

• Significant differential expression of microRNAs (miRNAs), piwi-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), and small nuclear RNAs (snRNAs) was observed during M1 and M2 macrophage polarization.
• Specific miRNAs (e.g., miR-novel-3-nature, miR-27b-5p) and piRNAs (e.g., DQ551351) were found to promote M1 macrophage polarization markers like TNF-α.
• Overexpression of certain piRNAs and snRNAs demonstrated the ability to enhance the antitumor activity of M1 macrophages, while one snoRNA inhibited TNF-α expression.

Conclusions:

• This study provides the first comprehensive report on the expression changes of piRNAs, snoRNAs, snRNAs, and repeat RNAs during macrophage polarization.
• Preliminary evidence suggests that piRNAs, snoRNAs, and snRNAs can actively regulate macrophage polarization and function.
• These findings highlight the potential of specific sncRNAs as novel regulators of immune responses and therapeutic targets in macrophage-related diseases.